Our earlier work on another blood based CRC screening assay, ColoDefense test that combines the detection of SEPT9 and SDC2 methylation in a single qPCR reaction, also improved the detection rates for early stage CRC and AA (Chen Y. et al., 2019; Zhao et al., 2019). This evidence concerns the gene SEPTIN9 and colorectal carcinoma.